AMPH logo

AMPH EBIT

annual EBIT:

$220.11M+$21.59M(+10.88%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AMPH annual earnings before interest & taxes is $220.11 million, with the most recent change of +$21.59 million (+10.88%) on December 31, 2024.
  • During the last 3 years, AMPH annual EBIT has risen by +$135.08 million (+158.88%).
  • AMPH annual EBIT is now at all-time high.

Performance

AMPH EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHincome statement metrics

quarterly EBIT:

$37.15M-$13.24M(-26.27%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AMPH quarterly earnings before interest & taxes is $37.15 million, with the most recent change of -$13.24 million (-26.27%) on March 31, 2025.
  • Over the past year, AMPH quarterly EBIT has dropped by -$19.34 million (-34.24%).
  • AMPH quarterly EBIT is now -51.97% below its all-time high of $77.34 million, reached on September 30, 2023.

Performance

AMPH quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHincome statement metrics

TTM EBIT:

$200.77M-$19.34M(-8.79%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AMPH TTM earnings before interest & taxes is $200.77 million, with the most recent change of -$19.34 million (-8.79%) on March 31, 2025.
  • Over the past year, AMPH TTM EBIT has dropped by -$20.27 million (-9.17%).
  • AMPH TTM EBIT is now -17.54% below its all-time high of $243.48 million, reached on June 30, 2024.

Performance

AMPH TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

AMPH EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.9%-34.2%-9.2%
3 y3 years+158.9%+26.4%+83.9%
5 y5 years+264.7%+531.7%+2671.1%

AMPH EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+158.9%-52.0%+60.4%-17.5%+94.1%
5 y5-yearat high+4292.5%-52.0%+658.3%-17.5%+4517.5%
alltimeall timeat high+803.1%-52.0%+470.8%-17.5%+775.5%

AMPH EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$37.15M(-26.3%)
$200.77M(-8.8%)
Dec 2024
$220.11M(+10.9%)
$50.39M(-7.3%)
$220.11M(-0.2%)
Sep 2024
-
$54.38M(-7.6%)
$220.52M(-9.4%)
Jun 2024
-
$58.85M(+4.2%)
$243.48M(+10.2%)
Mar 2024
-
$56.49M(+11.2%)
$221.04M(+11.3%)
Dec 2023
$198.52M(+68.4%)
$50.80M(-34.3%)
$198.52M(+4.8%)
Sep 2023
-
$77.34M(+112.4%)
$189.50M(+40.0%)
Jun 2023
-
$36.41M(+7.2%)
$135.33M(+10.5%)
Mar 2023
-
$33.97M(-18.7%)
$122.47M(+3.9%)
Dec 2022
$117.89M(+38.7%)
$41.79M(+80.4%)
$117.89M(+14.0%)
Sep 2022
-
$23.16M(-1.6%)
$103.43M(-12.7%)
Jun 2022
-
$23.55M(-19.9%)
$118.44M(+8.5%)
Mar 2022
-
$29.39M(+7.5%)
$109.19M(+28.4%)
Dec 2021
$85.02M(+1596.7%)
$27.33M(-28.4%)
$85.02M(+66.6%)
Sep 2021
-
$38.17M(+166.9%)
$51.04M(+153.7%)
Jun 2021
-
$14.30M(+174.1%)
$20.12M(+362.7%)
Mar 2021
-
$5.22M(-178.4%)
$4.35M(-13.2%)
Dec 2020
$5.01M(-91.7%)
-$6.65M(-191.7%)
$5.01M(-61.1%)
Sep 2020
-
$7.25M(-593.7%)
$12.89M(+78.0%)
Jun 2020
-
-$1.47M(-125.0%)
$7.25M(-89.6%)
Mar 2020
-
$5.88M(+378.5%)
$69.83M(+15.7%)
Dec 2019
$60.35M(-723.2%)
$1.23M(-23.4%)
$60.35M(+1.1%)
Sep 2019
-
$1.60M(-97.4%)
$59.71M(-1.8%)
Jun 2019
-
$61.12M(-1796.3%)
$60.80M(-1477.2%)
Mar 2019
-
-$3.60M(-710.7%)
-$4.42M(-54.4%)
DateAnnualQuarterlyTTM
Dec 2018
-$9.68M(-566.7%)
$590.00K(-78.1%)
-$9.68M(-14.2%)
Sep 2018
-
$2.70M(-165.8%)
-$11.28M(-28.7%)
Jun 2018
-
-$4.10M(-53.8%)
-$15.83M(+90.2%)
Mar 2018
-
-$8.87M(+777.4%)
-$8.32M(-470.9%)
Dec 2017
$2.08M(-86.7%)
-$1.01M(-45.4%)
$2.24M(-237.7%)
Sep 2017
-
-$1.85M(-154.3%)
-$1.63M(-125.1%)
Jun 2017
-
$3.41M(+101.2%)
$6.50M(-50.6%)
Mar 2017
-
$1.70M(-134.7%)
$13.15M(-16.0%)
Dec 2016
$15.65M(-266.9%)
-$4.88M(-177.8%)
$15.65M(-49.6%)
Sep 2016
-
$6.28M(-37.5%)
$31.08M(+49.8%)
Jun 2016
-
$10.06M(+139.5%)
$20.75M(+2956.7%)
Mar 2016
-
$4.20M(-60.2%)
$679.00K(-107.2%)
Dec 2015
-$9.38M(-46.5%)
$10.54M(-360.7%)
-$9.38M(-64.3%)
Sep 2015
-
-$4.04M(-59.6%)
-$26.29M(-11.6%)
Jun 2015
-
-$10.02M(+71.1%)
-$29.72M(+40.8%)
Mar 2015
-
-$5.86M(-8.0%)
-$21.10M(+20.3%)
Dec 2014
-$17.54M(-196.4%)
-$6.37M(-14.9%)
-$17.54M(+114.7%)
Sep 2014
-
-$7.48M(+434.3%)
-$8.17M(+5069.6%)
Jun 2014
-
-$1.40M(-38.9%)
-$158.00K(-101.2%)
Mar 2014
-
-$2.29M(-176.3%)
$13.40M(-26.3%)
Dec 2013
$18.18M(-31.8%)
$3.00M(+466.6%)
$18.18M(+19.8%)
Sep 2013
-
$530.00K(-95.6%)
$15.18M(+3.6%)
Jun 2013
-
$12.16M(+387.0%)
$14.65M(+487.0%)
Mar 2013
-
$2.50M
$2.50M
Dec 2012
$26.66M(-185.2%)
-
-
Dec 2011
-$31.30M
-
-

FAQ

  • What is Amphastar Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual EBIT year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly EBIT year-on-year change?
  • What is Amphastar Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals TTM EBIT year-on-year change?

What is Amphastar Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of AMPH is $220.11M

What is the all time high annual EBIT for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual earnings before interest & taxes is $220.11M

What is Amphastar Pharmaceuticals annual EBIT year-on-year change?

Over the past year, AMPH annual earnings before interest & taxes has changed by +$21.59M (+10.88%)

What is Amphastar Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of AMPH is $37.15M

What is the all time high quarterly EBIT for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly earnings before interest & taxes is $77.34M

What is Amphastar Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, AMPH quarterly earnings before interest & taxes has changed by -$19.34M (-34.24%)

What is Amphastar Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of AMPH is $200.77M

What is the all time high TTM EBIT for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high TTM earnings before interest & taxes is $243.48M

What is Amphastar Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, AMPH TTM earnings before interest & taxes has changed by -$20.27M (-9.17%)
On this page